- Report
- April 2024
- 284 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- April 2025
- 97 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 89 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 199 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- May 2024
- 169 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- September 2024
- 100 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- March 2024
- 143 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- January 2025
- 118 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Biocompatible scaffolds are a type of biomaterial used in tissue engineering and regenerative medicine. They are designed to provide a three-dimensional structure for cells to attach and grow on, and to provide a supportive environment for the cells to differentiate and form new tissue. Biocompatible scaffolds are typically made from biodegradable polymers, such as polylactic acid, polyglycolic acid, and polycaprolactone, and can be tailored to meet the specific needs of the tissue being regenerated.
The biocompatible scaffold market is growing rapidly, driven by the increasing demand for tissue engineering and regenerative medicine applications. The market is expected to benefit from the increasing number of research and development activities in the field, as well as the increasing number of clinical trials.
Some of the major companies in the biocompatible scaffold market include Corbion, DSM, Evonik Industries, Invibio, Polyganics, and Stryker. Show Less Read more